BRD2 and neoplasm: MAPs for which the sequence was the same as the reference genome and overexpressed at least 10-fold in tumor compared with normal were classified as aberrantly expressed TSAs (aeTSAs) if they had no or residual RNA expression (≤0.2 KPHM) in mTECs (and NAT in the case of tissues) or as TAAs if their expression in mTEC and/or NAT was greater than 0.2 KPHM.